In short
This article discusses the use of Anhydrous Glucose BP in clinical trials, specifically focusing on a study investigating insulin resistance in kidney transplant recipients and patients with chronic kidney disease. The trial aims to assess the effects of Pravastatin on insulin sensitivity and related factors in these patient groups. Understanding the role of glucose in this context is crucial for evaluating the study's methodology and potential outcomes.
At a glance
- Trial Name
- Insulin Resistance and Statin Treatment in Renal Transplant Recipients and Patients with Chronic Kidney Disease
- Main Objective
- To assess the effect of Pravastatin on insulin sensitivity compared to placebo
- Primary Endpoint
- Insulin sensitivity assessed by hyperinsulinemic euglycemic glucose clamp
- Study Population
- Kidney transplant recipients and patients with chronic kidney disease stage 3
- Age Range
- 40-70 years
- BMI Requirement
- 20-30 kg/m2
- Key Exclusion Criteria
- Pre-existing diabetes, high blood pressure, active liver disease
- Use of Anhydrous Glucose BP
- Part of the glucose clamp technique for measuring insulin sensitivity
- Data Sharing
- Available to researchers with approved proposals for 5 years post-publication
What is Anhydrous Glucose BP?
Anhydrous Glucose BP is a medical-grade form of glucose, which is a simple sugar that serves as a primary source of energy for your body. The "BP" in its name stands for "British Pharmacopoeia," indicating that it meets specific quality standards. This substance is also known by its synonym, Glucose anhydrous BP.
It's important to note that in medical contexts, Anhydrous Glucose BP is often used interchangeably or in combination with Glucose Monohydrate Ph. Eur. (European Pharmacopoeia standard). Both forms are classified under the broader category of carbohydrates in medical terminology.
Medical Uses
Anhydrous Glucose BP is primarily used in medical settings for various purposes:
- Energy Source: It provides a quick source of energy for patients who cannot eat or drink normally.
- Hydration: When mixed with water, it can help maintain proper hydration levels in the body.
- Blood Sugar Regulation: In some cases, it may be used to treat low blood sugar (hypoglycemia).
- Nutritional Support: It can be part of a broader nutritional therapy for patients who cannot receive nutrients orally.
While not directly related to Anhydrous Glucose BP, it's worth noting that current research is exploring its potential role in studies related to insulin resistance, particularly in patients with kidney issues.
How is it Administered?
Anhydrous Glucose BP is typically administered intravenously (IV), which means it's given directly into a vein. This method allows for quick absorption and utilization by the body. The intravenous route is particularly useful in hospital settings or emergency situations where rapid delivery of glucose is necessary.
Dosage Information
The dosage of Anhydrous Glucose BP can vary significantly depending on the patient's specific needs and medical condition. However, based on the available information:
- The maximum daily dose is typically up to 275 grams.
- The maximum total dose over a treatment period can be up to 550 grams.
- The maximum treatment period is usually around 2 days.
It's crucial to understand that these are maximum amounts, and actual doses are determined by healthcare professionals based on individual patient needs.
Current Research Focus
While the provided information doesn't directly relate to new uses for Anhydrous Glucose BP, it does mention an ongoing study that might indirectly involve its use:
- Insulin Resistance Study: Researchers are investigating the effects of a drug called Pravastatin on insulin sensitivity in kidney transplant recipients and patients with chronic kidney disease. While this study doesn't directly use Anhydrous Glucose BP, it's possible that glucose solutions might be used in the research process, particularly in procedures like the hyperinsulinemic euglycemic glucose clamp, which is mentioned as a primary endpoint.
This research could potentially lead to new insights into how glucose is processed in patients with kidney issues, which might indirectly impact how Anhydrous Glucose BP is used in the future.
Important Considerations
When receiving Anhydrous Glucose BP or any glucose solution, it's important to be aware of the following:
- Medical Supervision: This product is administered under strict medical supervision, typically in a hospital or clinical setting.
- Glucose Intolerance: Patients with hereditary glucose/galactose malabsorption should inform their healthcare providers, as this could affect how the body processes the glucose.
- Diabetes: If you have diabetes, your healthcare team will need to monitor your blood sugar levels closely when receiving glucose solutions.
- Kidney Function: Patients with kidney issues may need special consideration when receiving glucose solutions, as the kidneys play a role in glucose regulation.
Always provide your full medical history to your healthcare team before receiving any treatment, including glucose solutions like Anhydrous Glucose BP.